John Eric Hug

Array ( [id] => 7662374 [patent_doc_number] => 20110311643 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-22 [patent_title] => 'SUPPLEMENTED MATRICES FOR THE REPAIR OF BONE FRACTURES' [patent_app_type] => utility [patent_app_number] => 13/167488 [patent_app_country] => US [patent_app_date] => 2011-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 14998 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20110311643.pdf [firstpage_image] =>[orig_patent_app_number] => 13167488 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8270438 [patent_doc_number] => 08211944 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-03 [patent_title] => 'Amino acid based compositions for the treatment of pathological conditions distinguished by insufficient mitochondrial function' [patent_app_type] => utility [patent_app_number] => 13/161232 [patent_app_country] => US [patent_app_date] => 2011-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5349 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 217 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13161232 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8549396 [patent_doc_number] => 08324278 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-04 [patent_title] => 'Amino acid based compositions for the treatment of pathological conditions distinguished by insufficient mitochondrial function' [patent_app_type] => utility [patent_app_number] => 13/161240 [patent_app_country] => US [patent_app_date] => 2011-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5367 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 154 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13161240 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7587283 [patent_doc_number] => 20110281793 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-17 [patent_title] => 'Method For Reducing Cardiovascular Morbidity And Mortality In Prediabetic Patients And Patients With Type 2 Diabetes' [patent_app_type] => utility [patent_app_number] => 13/152932 [patent_app_country] => US [patent_app_date] => 2011-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11134 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20110281793.pdf [firstpage_image] =>[orig_patent_app_number] => 13152932 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8892198 [patent_doc_number] => 20130165382 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-27 [patent_title] => 'CROSSLINKING OF PROTEINS AND OTHER ENTITIES VIA CONJUGATES OF ALPHA-HALOACETOPHENONES, BENZYL HALIDES, QUINONES, AND THEIR DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 13/700944 [patent_app_country] => US [patent_app_date] => 2011-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32298 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13700944 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11487083 [patent_doc_number] => 09593147 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-03-14 [patent_title] => 'IgA-binding peptide and purification of IgA using the same' [patent_app_type] => utility [patent_app_number] => 13/699579 [patent_app_country] => US [patent_app_date] => 2011-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 10301 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13699579 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9427640 [patent_doc_number] => 08703714 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-22 [patent_title] => 'Monomethylvaline compounds capable of conjugation to ligands' [patent_app_type] => utility [patent_app_number] => 13/098391 [patent_app_country] => US [patent_app_date] => 2011-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 43 [patent_no_of_words] => 80719 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13098391 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8257841 [patent_doc_number] => 08207322 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-06-26 [patent_title] => 'Fluorescent protein and chromoprotein' [patent_app_type] => utility [patent_app_number] => 13/095603 [patent_app_country] => US [patent_app_date] => 2011-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 19099 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13095603 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8649740 [patent_doc_number] => 20130035470 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-07 [patent_title] => 'CRYSTALLINE OXIDIZED GLUTATHIONE AND PRODUCTION METHOD THEREFOR' [patent_app_type] => utility [patent_app_number] => 13/642356 [patent_app_country] => US [patent_app_date] => 2011-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3777 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13642356 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8995002 [patent_doc_number] => 08518886 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-27 [patent_title] => 'Cytoprotective thereapeutic agents for the prevention of reperfusion injury following ischemic stroke' [patent_app_type] => utility [patent_app_number] => 13/089697 [patent_app_country] => US [patent_app_date] => 2011-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9832 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13089697 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7766227 [patent_doc_number] => 20120034246 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-09 [patent_title] => 'MONOMETHYLVALINE COMPOUNDS CAPABLE OF CONJUGATION TO LIGANDS' [patent_app_type] => utility [patent_app_number] => 13/090246 [patent_app_country] => US [patent_app_date] => 2011-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 80607 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20120034246.pdf [firstpage_image] =>[orig_patent_app_number] => 13090246 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8066215 [patent_doc_number] => 20110243920 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-06 [patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING COLLAGEN-MEDIATED DISEASES' [patent_app_type] => utility [patent_app_number] => 13/084735 [patent_app_country] => US [patent_app_date] => 2011-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 95 [patent_figures_cnt] => 95 [patent_no_of_words] => 43263 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0243/20110243920.pdf [firstpage_image] =>[orig_patent_app_number] => 13084735 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8066257 [patent_doc_number] => 20110243909 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-06 [patent_title] => 'Compositions and Methods for Treating Collagen-Mediated Diseases' [patent_app_type] => utility [patent_app_number] => 13/084734 [patent_app_country] => US [patent_app_date] => 2011-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 94 [patent_figures_cnt] => 94 [patent_no_of_words] => 43291 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0243/20110243909.pdf [firstpage_image] =>[orig_patent_app_number] => 13084734 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6110153 [patent_doc_number] => 20110189153 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-04 [patent_title] => 'Compositions and Methods for Treating Collagen-Mediated Diseases' [patent_app_type] => utility [patent_app_number] => 13/084716 [patent_app_country] => US [patent_app_date] => 2011-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 94 [patent_figures_cnt] => 94 [patent_no_of_words] => 43546 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0189/20110189153.pdf [firstpage_image] =>[orig_patent_app_number] => 13084716 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6110199 [patent_doc_number] => 20110189163 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-04 [patent_title] => 'Compositions and Methods for Treating Collagen-Mediated Diseases' [patent_app_type] => utility [patent_app_number] => 13/084719 [patent_app_country] => US [patent_app_date] => 2011-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 94 [patent_figures_cnt] => 94 [patent_no_of_words] => 43365 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0189/20110189163.pdf [firstpage_image] =>[orig_patent_app_number] => 13084719 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8066275 [patent_doc_number] => 20110243908 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-06 [patent_title] => 'Compositions and Methods for Treating Collagen-Mediated Diseases' [patent_app_type] => utility [patent_app_number] => 13/084722 [patent_app_country] => US [patent_app_date] => 2011-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 94 [patent_figures_cnt] => 94 [patent_no_of_words] => 43578 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0243/20110243908.pdf [firstpage_image] =>[orig_patent_app_number] => 13084722 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8066217 [patent_doc_number] => 20110243919 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-06 [patent_title] => 'Compositions and Methods for Treating Collagen-Mediated Diseases' [patent_app_type] => utility [patent_app_number] => 13/084720 [patent_app_country] => US [patent_app_date] => 2011-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 94 [patent_figures_cnt] => 94 [patent_no_of_words] => 43566 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0243/20110243919.pdf [firstpage_image] =>[orig_patent_app_number] => 13084720 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7510866 [patent_doc_number] => 20110256608 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-20 [patent_title] => 'Modified Variant Bowman Birk Protease Inhibitors' [patent_app_type] => utility [patent_app_number] => 13/082979 [patent_app_country] => US [patent_app_date] => 2011-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 117771 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0256/20110256608.pdf [firstpage_image] =>[orig_patent_app_number] => 13082979 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7484698 [patent_doc_number] => 20110250255 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-13 [patent_title] => 'DRUG COATED STENT WITH ENDOSOME-DISRUPTING CONJUGATE' [patent_app_type] => utility [patent_app_number] => 13/078686 [patent_app_country] => US [patent_app_date] => 2011-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8378 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0250/20110250255.pdf [firstpage_image] =>[orig_patent_app_number] => 13078686 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9677140 [patent_doc_number] => 08816051 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-08-26 [patent_title] => 'Conjugated biological molecules and their preparation' [patent_app_type] => utility [patent_app_number] => 13/077980 [patent_app_country] => US [patent_app_date] => 2011-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 11462 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13077980 [rel_patent_id] =>[rel_patent_doc_number] =>)